Washington Trust Advisors’s Privia Health PRVA Stock Holding History

Washington Trust Advisors’s Portfolio PRVA Stock Details PRVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-385	Closed	-$9.59K	–	669
2025 Q3	$9.59K	Hold	385	–	–	﹤0.01%	525
2025 Q2	$8.86K	Buy	385 +104	+37%	+$2.41K	﹤0.01%	496
2025 Q1	$6.31K	Hold	281	–	–	﹤0.01%	528
2024 Q4	$5.49K	Hold	281	–	–	﹤0.01%	553
2024 Q3	$5.12K	Hold	281	–	–	﹤0.01%	570
2024 Q2	$4.88K	Hold	281	–	–	﹤0.01%	561
2024 Q1	$5.5K	Hold	281	–	–	﹤0.01%	559
2023 Q4	$6.47K	Hold	281	–	–	﹤0.01%	541
2023 Q3	$6.46K	Buy	281 +52	+23%	+$1.32K	﹤0.01%	521
2023 Q2	$5.98K	Hold	229	–	–	﹤0.01%	522
2023 Q1	$6.32K	Buy	229 +64	+39%	+$1.69K	﹤0.01%	566
2022 Q4	$3.75K	Hold	165	–	–	﹤0.01%	645
2022 Q3	$6K	Hold	165	–	–	﹤0.01%	688
2022 Q2	$5K	Sell	165 -40	-20%	-$1.02K	﹤0.01%	753
2022 Q1	$5K	Buy	205 +71	+53%	+$1.68K	﹤0.01%	825
2021 Q4	$3K	Buy	+134	New	+$3.34K	﹤0.01%	936

Other funds holding PRVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Washington Trust Advisors's PRVA Position: Q4 2025 in Review

Washington Trust Advisors sold out of Privia Health (PRVA) in Q4 2025, closing a stake of 385 shares — an estimated $9.59K sold.

Washington Trust Advisors first reported a position in PRVA in Q4 2021 and held it in 16 quarters. The position peaked at $9.59K in Q3 2025. 276 funds tracked by Wall St. Rank hold PRVA as of Q4 2025.

Washington Trust Advisors reported no remaining Privia Health position as of Q4 2025 after selling out during the quarter.
Washington Trust Advisors sold 385 Privia Health shares in Q4 2025, an estimated $9.59K.
Washington Trust Advisors first reported a position in Privia Health in Q4 2021 and held it in 16 quarters.
Washington Trust Advisors's Privia Health position peaked at $9.59K in Q3 2025.
276 funds tracked by Wall St. Rank held Privia Health as of Q4 2025.

Based on Washington Trust Advisors's 13F filing for Q4 2025, filed 3 Feb 2026.